GNLKQ (Genelink) Net Margin %: -182.71% (As of Sep. 2013)

Author: Vera Yuan Vera Yuan
Vera Yuan
Vera Yuan
Director of Data and Quant Analytics at GuruFocus
Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Reviewed by: Charlie Tian Charlie Tian
Charlie Tian
Charlie Tian
Founder & CEO of GuruFocus
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.

What is Genelink Net Margin %?

Genelink GNLKQ Net Margin % is -182.71% as of Sep. 2013.

Net margin is calculated as Net Income divided by its Revenue. Genelink's Net Income for the three months ended in Sep. 2013 was $-0.54 Mil. Genelink's Revenue for the three months ended in Sep. 2013 was $0.30 Mil. Therefore, Genelink's net margin for the quarter that ended in Sep. 2013 was -182.71%.

The historical rank and industry rank for Genelink's Net Margin % or its related term are showing as below:


GNLKQ's Net Margin % is not ranked *
in the Biotechnology industry.
Industry Median: -82.44
* Ranked among companies with meaningful Net Margin % only.

Genelink  (OTCPK:GNLKQ) Net Margin % Explanation

Although Net Income and Earnings-per-Share (EPS) are the most widely used parameter in measuring a company's profitability and valuation, it is the least reliable. The reason is that reported earnings can be manipulated easily by adjusting any numbers such as Depreciation, Depletion and Amotorization and non-recurring items.

But the long term trend of the net margin is a good indicator of the competitiveness and health of the business.

Genelink Net Margin % Related Terms

Genelink Net Margin % Historical Data

* Premium members only.

The historical data trend for Genelink's Net Margin % can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Genelink Net Margin % Chart

Genelink Annual Data
Trend Dec03 Dec04 Dec05 Dec06 Dec07 Dec08 Dec09 Dec10 Dec11 Dec12
Net Margin %
Get a 7-Day Free Trial Premium Member Only Premium Member Only -40.83 -31.74 -33.61 -81.75 -142.88

Genelink Quarterly Data
Dec08 Mar09 Jun09 Sep09 Dec09 Mar10 Jun10 Sep10 Dec10 Mar11 Jun11 Sep11 Dec11 Mar12 Jun12 Sep12 Dec12 Mar13 Jun13 Sep13
Net Margin % Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only -229.18 -244.90 -88.50 -52.25 -182.71

GNLKQ vs VITIF, HSTC, NTRR: Net Margin % Comparison

For the Biotechnology subindustry, Genelink's Net Margin %, along with its competitors' market caps and Net Margin % data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

Genelink Net Margin % vs Biotechnology Industry

For the Biotechnology industry and Healthcare sector, Genelink's Net Margin % distribution charts can be found below:

* The bar in red indicates where Genelink's Net Margin % falls into.


Genelink Net Margin % Calculation

Net margin - also known as net profit margin is the ratio of Net Income divided by net sales or Revenue, usually presented in percent.

Genelink's Net Margin for the fiscal year that ended in Dec. 2012 is calculated as

Net Margin=Net Income (A: Dec. 2012 )/Revenue (A: Dec. 2012 )
=-3.052/2.136
=-142.88 %

Genelink's Net Margin for the quarter that ended in Sep. 2013 is calculated as

Net Margin=Net Income (Q: Sep. 2013 )/Revenue (Q: Sep. 2013 )
=-0.539/0.295
=-182.71 %

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Frequently Asked Questions Learn more about Net Margin % →
What does a Net Margin % of -182.71% mean?
Genelink (GNLKQ) has a Net Margin % of -182.71% as of Sep. 2013. Net margin is the ratio of total net income to net sales. View historical data on Genelink and its competitors.
Is Genelink's Net Margin % too high?
Genelink's current Net Margin % is -182.71%.
How does Genelink's Net Margin % compare to VITIF and HSTC?
Genelink's Net Margin % of -182.71% can be compared against companies in the Biotechnology industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Net Margin % for a Biotechnology company?
A good Net Margin % depends on the Biotechnology industry context. However, Net Margin % should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Net Margin % mean?
A high Net Margin % can signal that a stock is expensive relative to its fundamentals. Net margin is the ratio of total net income to net sales. View historical data on Genelink and its competitors. Genelink's current Net Margin % is -182.71%. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Genelink stock overvalued right now?
Genelink (GNLKQ) has a current Net Margin % of -182.71%. The current Net Margin % is -182.71%. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Net Margin % calculated?
Net Margin % is calculated from a company's financial statements. For Genelink (GNLKQ), the current Net Margin % is -182.71% as of Sep. 2013. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Genelink Business Description

Address 8250 Exchange Drive, Suite 120, Orlando, FL, USA, 32809
Genelink Inc is a genetics-based, personal healthcare firm that has developed DNA assessments measuring personal DNA tendencies. These small differences in DNA, called SNPs can indicate genetic variants, the protein products of which may not be performing at optimal levels and can be linked to aging and other wellness issues. The company's scientists use the DNA assessments information from each client to formulate products to optimize health and wellness within normal ranges. The company has a compilation of issued and pending patents that center on using DNA analysis for the purpose of customizing nutrition and skin care formulations for wellness and anti-aging.